Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.35 |
| ▸ | ACP1 | P24666 | 1/20 | 0.35 |
| ▸ | RORC | P51449 | 2/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14029516 | 0.88 | SERPINE1 (0.37) | PTGESALDH1A1L3MBTL1NPY5RRORC | |
| SCHEMBL14029485 | 0.85 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1KDM4ENPY5RTSPO | |
| SCHEMBL26529151 | 0.83 | LDHA (0.40) | ALDH1A1L3MBTL1MAPTKDM4EEPHX2 | |
| SCHEMBL26529084 | 0.83 | LDHA (0.40) | ALDH1A1L3MBTL1MAPTKDM4EEPHX2 | |
| SCHEMBL26529170 | 0.83 | LDHA (0.40) | ALDH1A1L3MBTL1MAPTKDM4EEPHX2 | |
| SCHEMBL21116344 | 0.82 | TSPO (0.40) | PTGESALDH1A1L3MBTL1KDM4ENPY5R | |
| SCHEMBL14029463 | 0.81 | JUN (0.38) | ALDH1A1L3MBTL1MAPTRORCTSPO | |
| SCHEMBL14029540 | 0.81 | TSPO (0.38) | ALDH1A1L3MBTL1MAPTKDM4ETSPO | |
| SCHEMBL14029483 | 0.81 | KDM4E (0.42) | PTGESL3MBTL1KDM4ENPY5RACP1 | |
| SCHEMBL14029479 | 0.81 | GSK3B (0.41) | ALDH1A1L3MBTL1MAPTKDM4EACP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11171292-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-20200373488-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2020-11-26 | — | — | US | disclosed |
| US-20180083191-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2018-03-22 | — | — | US | disclosed |
| US-9831440-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-11-28 | — | — | US | disclosed |
| US-20170018711-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2017-01-19 | — | — | US | disclosed |
| US-9461248-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20150005509-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2015-01-01 | — | — | US | disclosed |
| US-8835018-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-09-16 | — | — | US | disclosed |
| US-8835018-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-09-16 | — | — | US | disclosed |
| EP-1985613-B1 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LAB (JP) | 2013-05-15 | — | — | EP | disclosed |
| US-20080268284-A1 | Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080268284-A1 | Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| EP-1985613-A2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080268284-A1 | Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption | CRY1, CRY2, CYBA | PTGES 2769/4885ALDH1A1 67/4885L3MBTL1 3828/4885 |
| US-20170018711-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | CYP1A1, CYP1A2, XPOT | PTGES 685/4885ALDH1A1 59/4885L3MBTL1 1845/4885 |
| US-20200373488-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | CYP1A1, CYP1A2, XPOT | PTGES 685/4885ALDH1A1 59/4885L3MBTL1 1845/4885 |
| US-11171292-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | CYP1A1, CYP1A2, XPOT | PTGES 685/4885ALDH1A1 59/4885L3MBTL1 1845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.